
Liberumbio combines machine learning with cell-free biology to accelerate enzyme and antibody discovery, offering proprietary high-yield cell-free reagents, cartridges for scale-up and purification, protein synthesis services, and library design to improve enzyme activity and antibody binding. Their cell-free system enables rapid generation of actionable biological data at lower cost and faster speeds than existing solutions, positioning them as a disruptive force in protein discovery and synthetic biology markets.

Liberumbio combines machine learning with cell-free biology to accelerate enzyme and antibody discovery, offering proprietary high-yield cell-free reagents, cartridges for scale-up and purification, protein synthesis services, and library design to improve enzyme activity and antibody binding. Their cell-free system enables rapid generation of actionable biological data at lower cost and faster speeds than existing solutions, positioning them as a disruptive force in protein discovery and synthetic biology markets.